Roche Holding AG (0QOK.IL)
IOB - IOB Delayed price. Currency in CHF
Add to watchlist
As of 09:54AM BST. Market open.
| Previous close | 230.65 |
| Open | 226.80 |
| Bid | 222.50 x N/A |
| Ask | 233.90 x N/A |
| Day's range | 226.80 - 230.10 |
| 52-week range | 212.30 - 298.40 |
| Volume | |
| Avg. volume | 911,750 |
| Market cap | 194.067B |
| Beta (5Y monthly) | 0.18 |
| PE ratio (TTM) | 17.59 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 9.50 (3.99%) |
| Ex-dividend date | 16 Mar 2023 |
| 1y target est | N/A |
- Zacks
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
- Zacks
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation
Roche's (RHHBY) inavolisib gets Breakthrough Therapy Designation in the United States for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
- Zacks
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen
Novo Nordisk, Eli Lilly's, Viking, Altimmune, Roche and Amgen are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.